Health Trials

About this trial

The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.

Eligibility criteria

Qualifiers

Patients ≥ 19 years old

Patients receiving Coroflex ISAR NEO stents.

The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Disqualifiers

Patients with a mixture of other DESs

Terminal illness with life expectancy <1 year.

Patients with cardiogenic shock

Trial design

Treatments tested in this trial

  • Coroflex ISAR NEO stent

Treatment groups

1,000 Participants
are divided into 1 treatment group

Locations

11
Asan Medical Center138-736, SeoulSongpa-gu, South Korea
Bucheon Sejong Hospital Bucheon-si South Korea
The Catholic Univ. of Korea BUCHEON ST.Mary's hospital Bucheon-si South Korea
Veterans Hospital Daegu South Korea

Sponsors and collaborators

Seung-Jung Park

Lead sponsor

Asan Medical Center

Sponsor institution

The CardioVascular Research Foundation (CVRF)

Collaborator

Source ClinicalTrials.gov